Laduviglusib trihydrochloride
CAS: 1782235-14-6
Ref. TM-T22657
| 1mg | 42.00 € | ||
| 2mg | 56.00 € | ||
| 5mg | 92.00 € | ||
| 10mg | 134.00 € | ||
| 25mg | 263.00 € | ||
| 50mg | 498.00 € | ||
| 100mg | 667.00 € | ||
| 500mg | 1,392.00 € | ||
| 1ml*10 (DMSO) | 104.00 € |
Estimated delivery in United States, on Wednesday 5 Jun 2024
Product Information
Name:
Laduviglusib trihydrochloride
Synonyms:
- CT99021 trihydrochloride, CHIR 99021 trihydrochloride, CHIR 99021 trihydrochloride (252917-06-9 free base)
CAS:
Description:
Laduviglusib trihydrochloride (CT99021 trihydrochloride) is a selective glycogen synthase kinase 3 (GSK-3) inhibitor with IC50s of 10 nM and 6.7 nM for GSK-3α and GSK-3β. Laduviglusib trihydrochloride inhibits human GSK-3β with a Ki of 9.8 nM. Laduviglusib trihydrochloride is an activator of Wnt/β-catenin signaling. Laduviglusib trihydrochloride induces autophagy.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
574.72
Formula:
C22H21Cl5N8
Purity:
99.03%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T22657 Laduviglusib trihydrochloride
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
